The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Toripalimab plus bevacizumab as first-line treatment for advanced hepatocellular carcinoma: A single-arm phase II study.
 
Chengyou Du
No Relationships to Disclose
 
Baogang Peng
No Relationships to Disclose
 
Wu Zhang
No Relationships to Disclose
 
Yunfeng Shan
No Relationships to Disclose
 
Ang Lv
No Relationships to Disclose
 
Jianhui Wu
No Relationships to Disclose
 
Changzhen Shang
No Relationships to Disclose
 
Xuan Luo
No Relationships to Disclose
 
Jinxing Wei
No Relationships to Disclose
 
Heng Xiao
No Relationships to Disclose
 
Jianguo Qiu
No Relationships to Disclose
 
Yunpeng Hua
No Relationships to Disclose
 
Shunli Shen
No Relationships to Disclose
 
Ting Wang
No Relationships to Disclose
 
Shengjie Dai
No Relationships to Disclose
 
Xiang Chen
Employment - Shanghai Junshi BioSciences
Stock and Other Ownership Interests - Shanghai Junshi BioSciences
Honoraria - Shanghai Junshi BioSciences
 
Shican Yan
Employment - Shanghai Junshi BioSciences
Stock and Other Ownership Interests - Shanghai Junshi BioSciences
Honoraria - Shanghai Junshi BioSciences
 
Chunyi Hao
No Relationships to Disclose